<SEC-DOCUMENT>0001213900-19-013620.txt : 20190725
<SEC-HEADER>0001213900-19-013620.hdr.sgml : 20190725
<ACCEPTANCE-DATETIME>20190725165846
ACCESSION NUMBER:		0001213900-19-013620
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190724
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190725
DATE AS OF CHANGE:		20190725

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			OptimizeRx Corp
		CENTRAL INDEX KEY:			0001448431
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				261265381
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38543
		FILM NUMBER:		19975081

	BUSINESS ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
		BUSINESS PHONE:		248-651-6558

	MAIL ADDRESS:	
		STREET 1:		400 WATER ST., STE. 200
		CITY:			ROCHESTER
		STATE:			MI
		ZIP:			48307
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k072419_optimize.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; text-align: center"><B>WASHINGTON, D.C. 20549<BR>
____________________</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0.25in; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>PURSUANT TO SECTION 13 OR 15(d) OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>THE SECURITIES EXCHANGE ACT OF 1934<BR>
<BR>
</B>Date of Report (Date of earliest event reported): July 24, 2019<BR>
<BR>
<U>OptimizeRx Corporation</U><BR>
(Exact name of registrant as specified in its charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; border-bottom: Black 1.5pt solid"><U STYLE="text-decoration: none">Nevada</U></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; border-bottom: Black 1.5pt solid"><U STYLE="text-decoration: none">000-53605</U></TD>
    <TD STYLE="width: 2%; border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; border-bottom: Black 1.5pt solid"><U STYLE="text-decoration: none">26-1265381</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0">(State or other jurisdiction of</P>
                                                                              <P STYLE="margin-top: 0; margin-bottom: 0">incorporation)</P></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(Commission File Number)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(I.R.S. Employer Identification No.)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; border-bottom: Black 1.5pt solid"><U STYLE="text-decoration: none">400 Water Street, Suite 200, Rochester, MI</U></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; border-bottom: Black 1.5pt solid"><U STYLE="text-decoration: none">48307</U></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(Address of principal executive offices)</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">(Zip Code)</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Registrant&rsquo;s telephone number, including area code: <U>248.651.6568</U>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
    <TD STYLE="width: 25%">&nbsp;</TD>
    <TD STYLE="width: 50%; border-bottom: Black 1.5pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 25%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; text-align: left">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">(Former name or former address, if changed since
        last report)</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD STYLE="width: 96%; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">&#9744;</FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Emerging growth company&nbsp;&nbsp;&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Securities registered pursuant to Section 12(b) of the Act:&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Title of each class</B></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Trading symbol</B></TD>
    <TD STYLE="width: 2%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 32%; border-bottom: black 1.5pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Name of each exchange on which registered</B></TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Common Stock</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">OPRX</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Nasdaq Capital Market</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: white"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 12pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: white"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>SECTION 2 &ndash; Financial Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 2.02</B></TD><TD><B>Results of Operations and Financial Condition.</B></TD></TR>
</TABLE></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">On July 24, 2019, we issued a press release announcing the details
of our earnings conference call, to be held on Wednesday, August 7, 2019 at 4:30 p.m. Eastern time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The press release is furnished with this Current Report on Form
8-K as Exhibit 99.1. The information furnished under this Item 2.02 and Item 9.01 of this Current Report on Form 8-K, including
Exhibit 99.1, shall not be deemed to be &ldquo;filed&rdquo; for the purposes of Section 18 of the Securities Exchange Act of 1934,
as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any registration
statement or other filing under the Securities Act of 1933, as amended, regardless of any general incorporation by reference language
in such filing, except as shall be expressly set forth by specific reference in any such filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>SECTION 9 &ndash; Financial Statements and Exhibits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"><B>Item 9.01</B></TD><TD><B>Financial Statements and Exhibits</B></TD></TR>                                                                                                                                                                                                                                                                                                                                                                                    <TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD>99.1</TD><TD><A HREF="f8k072419ex99-1_optimize.htm">Press release, dated July 24, 2019</A></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>OptimizeRx Corporation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><U>/s/ Douglas Baker</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Douglas Baker<BR>
Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Date: July 25, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>f8k072419ex99-1_optimize.htm
<DESCRIPTION>PRESS RELEASE, DATED JULY 24, 2019
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 5pt 0 14pt; text-align: center; color: Red"><IMG SRC="image_001.jpg" ALT=""></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>OptimizeRx Sets Second Quarter 2019 Conference
Call for Wednesday, August 7, 2019 at 4:30 p.m. ET</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0.25in 14pt 0"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>ROCHESTER, Mich. &ndash; July 24, 2019 &ndash; </B>OptimizeRx
Corp. (Nasdaq: OPRX), a leading platform for digital health messaging in the pharmaceutical industry, will hold a conference call
on Wednesday, August 7, 2019 at 4:30 p.m. Eastern time to discuss results for the second quarter ended June 30, 2019. The financial
results will be issued in a press release prior to the call.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">OptimizeRx management will host the call, followed by a question
and answer period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Date: Wednesday, August 7, 2019</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Toll-free dial-in number: 1-800-458-4121</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">International dial-in number: 1-323-794-2597</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Conference ID: 1609655</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Please call the conference telephone number five minutes prior
to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference
call, please contact CMA at 1-949-432-7566.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">A replay of the call will be available after 7:30 p.m. Eastern
time on the same day through August 28, 2019, as well as available for replay via the Investors section of the OptimizeRx website
at investors.optimizerx.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Toll-free replay number: 1-844-512-2921</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">International replay number: 1-412-317-6671</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Replay ID: 1609655</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-left: 0; color: #26282A"><B>About
OptimizeRx</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-right: 0; margin-left: 0; color: #26282A">OptimizeRx&reg;
(Nasdaq: OPRX), a digital health company, connects pharmaceutical companies to patients and providers, offering greater affordability,
adherence and brand awareness at the point-of-care. As the nation&rsquo;s largest point-of-prescribe promotional platform for
the pharmaceutical industry,&nbsp;OptimizeRx&nbsp;provides a direct channel for&nbsp;pharma&nbsp;companies to communicate with
healthcare providers right within their workflow.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0; margin-left: 0; background-color: white; color: #26282A">The
cloud-based solution supports patient adherence to medications with real-time access to financial assistance, prior authorization,
education and critical clinical information.&nbsp;OptimizeRx&nbsp;provides more than half of the ambulatory patient market with
access to these benefits through leading EHR platforms like&nbsp;Allscripts, Amazing Charts and Quest, and directly via its mobile
communications platform.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">For more information, follow the company on&#8239;Twitter,&#8239;LinkedIn&#8239;or
visit&#8239;www.optimizerx.com.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 12pt; background-color: white; color: #26282A"><B>Important Cautions
Regarding Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">This press release contains forward-looking statements within the
definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934,
as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible'
and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made.
The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information,
future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot
be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by,
or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include,
but are not limited to, the effect of government regulation, competition and other material risks.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>OptimizeRx&nbsp;Contact</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Doug Baker, CFO&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Tel (248) 651-6568 x807&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">dbaker@optimizerx.com&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Media Relations Contact</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Nicole Brooks,&nbsp;Innsena&nbsp;Communications&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Tel&nbsp;(860)&nbsp;800-2344&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">nicolebrooks@innsena.com&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Investor Relations Contact</B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Ron Both, CMA&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Tel (949) 432-7557&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">oprx@cma.team&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin-top: 0pt; text-align: center; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  _ 0H# 2(  A$! Q$!_\0
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MNNUOPW!KOA:30;FYG6&2-(VF7&\[2#GD8R<4VUS7'U)?#'_(IZ/_ ->4/_H
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M< HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
+!1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
